- Home
- Publications
- Publication Search
- Publication Details
Title
Current Options and Future Directions for NAFLD and NASH Treatment
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 22, Issue 14, Pages 7571
Publisher
MDPI AG
Online
2021-07-15
DOI
10.3390/ijms22147571
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Estimating global prevalence of metabolic dysfunction-associated fatty liver disease in overweight or obese adults
- (2021) Jiaye Liu et al. Clinical Gastroenterology and Hepatology
- Nonalcoholic fatty liver disease or metabolic dysfunction‐associated fatty liver disease diagnoses and cardiovascular diseases: From epidemiology to drug approaches
- (2021) Paola Dongiovanni et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Gut microbiota composition associated with hepatic fibrosis in non‐obese patients with non‐alcoholic fatty liver disease
- (2021) Michihiro Iwaki et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Sleeve Gastrectomy Versus Roux-en-Y Gastric Bypass in the Elderly: 1-Year Preliminary Outcomes in a Randomized Trial (BASE Trial)
- (2021) Denis Pajecki et al. OBESITY SURGERY
- G protein-coupled receptors as potential targets for nonalcoholic fatty liver disease treatment
- (2021) Ming Yang et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Dietary Polyphenols and Non-Alcoholic Fatty Liver Disease
- (2021) Ludovico Abenavoli et al. Nutrients
- Liraglutide Alleviates Hepatic Steatosis and Liver Injury in T2MD Rats via a GLP-1R Dependent AMPK Pathway
- (2021) Rui Zhou et al. Frontiers in Pharmacology
- MicroRNA-21 Plays Multiple Oncometabolic Roles in the Process of NAFLD-Related Hepatocellular Carcinoma via PI3K/AKT, TGF-β, and STAT3 Signaling
- (2021) Chi-Yu Lai et al. Cancers
- Inhibition of Estrogen-Related Receptor α Blocks Liver Steatosis and Steatohepatitis and Attenuates Triglyceride Biosynthesis
- (2021) Chien-yu Chen et al. AMERICAN JOURNAL OF PATHOLOGY
- Saroglitazar, a PPAR‐α/γ Agonist, for Treatment of Nonalcoholic Fatty Liver Disease: A Randomized Controlled Double‐Blind Phase 2 Trial
- (2021) Samer Gawrieh et al. HEPATOLOGY
- Novel insulin sensitizer MSDC-0602K improves insulinemia and fatty liver disease in mice, alone and in combination with liraglutide
- (2021) Dakota R. Kamm et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Lipid-induced endothelial vascular cell adhesion molecule 1 promotes nonalcoholic steatohepatitis pathogenesis
- (2021) Kunimaro Furuta et al. JOURNAL OF CLINICAL INVESTIGATION
- VCAM-1: closing the gap between lipotoxicity and endothelial dysfunction in nonalcoholic steatohepatitis
- (2021) Rotonya M. Carr JOURNAL OF CLINICAL INVESTIGATION
- Eugenol modulates insulin sensitivity by upregulating insulin receptor substrate-2 in non-alcoholic fatty liver disease in rats
- (2021) Mariam H Fawzy et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Association of metabolic–bariatric surgery with long-term survival in adults with and without diabetes: a one-stage meta-analysis of matched cohort and prospective controlled studies with 174 772 participants
- (2021) Nicholas L Syn et al. LANCET
- Effect of exercise on cardiometabolic health of adults with overweight or obesity: Focus on blood pressure, insulin resistance, and intrahepatic fat—A systematic review and meta‐analysis
- (2021) Francesca Battista et al. Obesity Reviews
- Effects of anti-diabetic treatments in type 2 diabetes and fatty liver disease
- (2021) Elizabeth M. Lamos et al. Expert Review of Clinical Pharmacology
- The Links of Ghrelin to Incretins, Insulin, Glucagon, and Leptin After Bariatric Surgery
- (2021) Daria Skuratovskaia et al. Frontiers in Genetics
- Glucagon-Like Peptide-1 Receptor Agonists for Non-Alcoholic Fatty Liver Disease in Type 2 Diabetes: A Meta-Analysis
- (2021) Chloe Wong et al. Frontiers in Endocrinology
- Long Working Hours and Risk of Nonalcoholic Fatty Liver Disease: Korea National Health and Nutrition Examination Survey VII
- (2021) Eyun Song et al. Frontiers in Endocrinology
- Performance of Fatty Liver Index in Identifying Non-Alcoholic Fatty Liver Disease in Population Studies. A Meta-Analysis
- (2021) Marco Castellana et al. Journal of Clinical Medicine
- Maternal Exercise Mediates Hepatic Metabolic Programming via Activation of AMPK-PGC1α Axis in the Offspring of Obese Mothers
- (2021) Philipp Kasper et al. Cells
- Thiazolidinediones and Glucagon‐Like Peptide‐1 Receptor Agonists and the Risk of Nonalcoholic Fatty Liver Disease: A Cohort Study
- (2021) Judith Dalem et al. HEPATOLOGY
- Transcriptomics Identify Thrombospondin‐2 as a Biomarker for NASH and Advanced Liver Fibrosis
- (2021) Kazuhiro Kozumi et al. HEPATOLOGY
- Population-specific cut-off points of fatty liver index for the diagnosis of hepatic steatosis
- (2021) Juan Wu et al. JOURNAL OF HEPATOLOGY
- A synthetic peptide AWRK6 ameliorates metabolic associated fatty liver disease: involvement of lipid and glucose homeostasis
- (2021) Lili Jin et al. PEPTIDES
- Cadmium chloride induces non-alcoholic fatty liver disease in rats by stimulating miR-34a/SIRT1/FXR/p53 axis
- (2021) Ali S. Alshehri et al. SCIENCE OF THE TOTAL ENVIRONMENT
- Roux-en-Y gastric bypass-induced bacterial perturbation contributes to altered host-bacterial co-metabolic phenotype
- (2021) Jia V. Li et al. Microbiome
- The Role of Lipid Profile as an Independent Predictor of Non-alcoholic Steatosis and Steatohepatitis in Morbidly Obese Patients
- (2021) Narges Ashraf Ganjooei et al. Frontiers in Cardiovascular Medicine
- Optimization of Metformin in the GRADE Cohort: Effect on Glycemia and Body Weight
- (2020) William I. Sivitz et al. DIABETES CARE
- Synbiotic Alters Fecal Microbiomes, but not Liver Fat or Fibrosis, in a Randomized Trial of Patients With Non-alcoholic Fatty Liver Disease
- (2020) Eleonora Scorletti et al. GASTROENTEROLOGY
- Cenicriviroc Treatment for Adults with Nonalcoholic Steatohepatitis and Fibrosis: Final Analysis of the Phase 2b CENTAUR Study
- (2020) Vlad Ratziu et al. HEPATOLOGY
- Cilofexor, a Nonsteroidal FXR Agonist, in Non‐Cirrhotic Patients with Nonalcoholic Steatohepatitis: A Phase 2 Randomized Controlled Trial
- (2020) Keyur Patel et al. HEPATOLOGY
- Selonsertib for Patients with Bridging Fibrosis or Compensated Cirrhosis Due to NASH: Results from Randomized Ph III STELLAR Trials
- (2020) Stephen A. Harrison et al. JOURNAL OF HEPATOLOGY
- Inevitable role of TGF-β1 in progression of nonalcoholic fatty liver disease
- (2020) Bhagyalakshmi Nair et al. JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION
- Allogenic Fecal Microbiota Transplantation in Patients With Nonalcoholic Fatty Liver Disease Improves Abnormal Small Intestinal Permeability
- (2020) Laura Craven et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Influence of adiposity, insulin resistance, and intrahepatic triglyceride content on insulin kinetics
- (2020) Gordon I. Smith et al. JOURNAL OF CLINICAL INVESTIGATION
- Standardization of Diet and Exercise in Clinical Trials of NAFLD-NASH: Recommendations from the Liver Forum
- (2020) Oliver Glass et al. JOURNAL OF HEPATOLOGY
- A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement
- (2020) Mohammed Eslam et al. JOURNAL OF HEPATOLOGY
- Gut metabolites and inflammation factors in non-alcoholic fatty liver disease: A systematic review and meta-analysis
- (2020) Xiongfeng Pan et al. Scientific Reports
- Silencing of functional p53 attenuates NAFLD by promoting HMGB1-related autophagy induction
- (2020) Xuequn Zhang et al. Hepatology International
- Effective Combination Therapy of Angiotensin-II Receptor Blocker and Rifaximin for Hepatic Fibrosis in Rat Model of Nonalcoholic Steatohepatitis
- (2020) Yukihisa Fujinaga et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Aberrant DNA methylation results in altered gene expression in non-alcoholic steatohepatitis-related hepatocellular carcinomas
- (2020) Ying Tian et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Schaftoside alleviates HFD-induced hepatic lipid accumulation in mice via upregulating farnesoid X receptor
- (2020) Meijing Liu et al. JOURNAL OF ETHNOPHARMACOLOGY
- p53 haploinsufficiency and increased mTOR signaling define a subset of aggressive hepatocellular carcinoma
- (2020) Yuan-Deng Luo et al. JOURNAL OF HEPATOLOGY
- The PPAR α/γ Agonist Saroglitazar Improves Insulin Resistance and Steatohepatitis in a Diet Induced Animal Model of Nonalcoholic Fatty Liver Disease
- (2020) Divya P. Kumar et al. Scientific Reports
- Hepatocyte nuclear factor 4α prevents the steatosis‐to‐NASH progression by regulating p53 and bile acid signaling
- (2020) Yanyong Xu et al. HEPATOLOGY
- Value of anti-p53 antibody as a biomarker for hepatocellular carcinoma
- (2020) Yue Chang et al. MEDICINE
- Diet Modifies Pioglitazone’s Influence on Hepatic PPARγ-Regulated Mitochondrial Gene Expression
- (2020) Sakil Kulkarni et al. PPAR Research
- Distinct signatures of gut microbiome and metabolites associated with significant fibrosis in non-obese NAFLD
- (2020) Giljae Lee et al. Nature Communications
- Vitamin E treatment in NAFLD patients demonstrates that oxidative stress drives steatosis through upregulation of de-novo lipogenesis
- (2020) Maren C. Podszun et al. Redox Biology
- The Potential Gut Microbiota-Mediated Treatment Options for Liver Cancer
- (2020) Chunye Zhang et al. Frontiers in Oncology
- Pioglitazone and bariatric surgery are the most effective treatments for non‐alcoholic steatohepatitis: A hierarchical network meta‐analysis
- (2020) Simona Panunzi et al. DIABETES OBESITY & METABOLISM
- Hepatic Krüppel-like factor 16 (KLF16) targets PPARα to improve steatohepatitis and insulin resistance
- (2020) Nannan Sun et al. GUT
- Deletion of KLF10 Leads to Stress-Induced Liver Fibrosis upon High Sucrose Feeding
- (2020) Junghoon Lee et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The pharmacodynamic and differential gene expression analysis of PPAR α/δ agonist GFT505 in CDAHFD-induced NASH model
- (2020) Linfu Liu et al. PLoS One
- Calorie-Restricted Mediterranean and Low-Fat Diets Affect Fatty Acid Status in Individuals with Nonalcoholic Fatty Liver Disease
- (2020) Danijela Ristic-Medic et al. Nutrients
- Combination Therapies Including Cilofexor and Firsocostat for Bridging Fibrosis and Cirrhosis Attributable to NASH
- (2020) Rohit Loomba et al. HEPATOLOGY
- A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis
- (2020) Philip N. Newsome et al. NEW ENGLAND JOURNAL OF MEDICINE
- Genetic and epigenetic factors determining NAFLD risk
- (2020) Wenke Jonas et al. Molecular Metabolism
- Non-Invasive Assessment of Liver Disease in Patients with NAFLD
- (2019) Laurent Castera et al. GASTROENTEROLOGY
- The nonsteroidal FXR agonist cilofexor (GS-9674) improves markers of cholestasis and liver injury in patients with PSC
- (2019) Michael Trauner et al. HEPATOLOGY
- Triglycerides to high-density lipoprotein cholesterol ratio as a surrogate for nonalcoholic fatty liver disease: a cross-sectional study
- (2019) Nengguang Fan et al. Lipids in Health and Disease
- Effect of a Low Free Sugar Diet vs Usual Diet on Nonalcoholic Fatty Liver Disease in Adolescent Boys
- (2019) Jeffrey B. Schwimmer et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Validation of PNPLA3 polymorphisms as risk factor for NAFLD and liver fibrosis in an admixed population
- (2019) Daniel F. Mazo et al. Annals of Hepatology
- miR-122 promotes hepatic lipogenesis via inhibiting the LKB1/AMPK pathway by targeting Sirt1 in non-alcoholic fatty liver disease
- (2019) Jun-Ke Long et al. MOLECULAR MEDICINE
- Impact of sleeve gastrectomy and Roux-en-Y gastric bypass on biopsy-proven non-alcoholic fatty liver disease
- (2019) Deepa V. Cherla et al. SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES
- Ets-1 deficiency alleviates nonalcoholic steatohepatitis via weakening TGF-β1 signaling-mediated hepatocyte apoptosis
- (2019) Dechen Liu et al. Cell Death & Disease
- Effects of Dietary Intervention on Gut Microbiota and Metabolic-Nutritional Profile of Outpatients with Non-Alcoholic Steatohepatitis: a Randomized Clinical Trial
- (2019) Fabiana De Faria Ghetti et al. Journal of Gastrointestinal and Liver Diseases
- Silymarin in non-cirrhotics with non-alcoholic steatohepatitis: A randomized, double-blind, placebo controlled trial
- (2019) Victor J. Navarro et al. PLoS One
- Effect of vitamin E in non-alcoholic fatty liver disease: a systematic review and meta-analysis of randomised controlled trials
- (2019) Iram Amanullah et al. POSTGRADUATE MEDICAL JOURNAL
- Metabolic and Endocrine Consequences of Bariatric Surgery
- (2019) Isabel Cornejo-Pareja et al. Frontiers in Endocrinology
- Vitamin E is an effective treatment for nonalcoholic steatohepatitis in HIV mono-infected patients
- (2019) Giada Sebastiani et al. AIDS
- Protective effect of metformin against palmitate-induced hepatic cell death
- (2019) Yana Geng et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Scoparone alleviates inflammation, apoptosis and fibrosis of non-alcoholic steatohepatitis by suppressing the TLR4/NF-κB signaling pathway in mice
- (2019) Beibei Liu et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Insulin sensitizer MSDC-0602K in non-alcoholic steatohepatitis: A randomized, double-blind, placebo-controlled phase IIb study
- (2019) Stephen A. Harrison et al. JOURNAL OF HEPATOLOGY
- LncRNA NEAT1 promotes hepatic lipid accumulation via regulating miR-146a-5p/ROCK1 in nonalcoholic fatty liver disease
- (2019) Xi Chen et al. LIFE SCIENCES
- miR-873-5p targets mitochondrial GNMT-Complex II interface contributing to non-alcoholic fatty liver disease
- (2019) Pablo Fernández-Tussy et al. Molecular Metabolism
- KLF15-activating Twist2 ameliorated hepatic steatosis by inhibiting inflammation and improving mitochondrial dysfunction via NF-κB–FGF21 or SREBP1c-FGF21 pathway
- (2019) Lulu Zhou et al. FASEB JOURNAL
- Active vitamin D supplementation alleviates initiation and progression of nonalcoholic fatty liver disease by repressing the p53 pathway
- (2019) Yuanyuan Liu et al. LIFE SCIENCES
- Anthropometric and blood parameters for the prediction of NAFLD among overweight and obese adults
- (2018) Tilman Kühn et al. BMC GASTROENTEROLOGY
- Acetyl-CoA Carboxylase Inhibitor GS-0976 for 12 Weeks Reduces Hepatic De Novo Lipogenesis and Steatosis in Patients With Nonalcoholic Steatohepatitis
- (2018) Eric J. Lawitz et al. Clinical Gastroenterology and Hepatology
- Diagnosis and Evaluation of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis, Including Noninvasive Biomarkers and Transient Elastography
- (2018) Eugenia Tsai et al. Clinics in Liver Disease
- Genetic and Epigenetic Regulation in Nonalcoholic Fatty Liver Disease (NAFLD)
- (2018) José Del Campo et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Aortic carboxypeptidase–like protein, a WNT ligand, exacerbates nonalcoholic steatohepatitis
- (2018) Toshiaki Teratani et al. JOURNAL OF CLINICAL INVESTIGATION
- Genetics and epigenetics of NAFLD and NASH: Clinical impact
- (2018) Mohammed Eslam et al. JOURNAL OF HEPATOLOGY
- Gut microbiota characterisation in obese patients before and after bariatric surgery
- (2018) G. Campisciano et al. Beneficial Microbes
- A randomised, double-blind, placebo-controlled phase 1 study of the safety, tolerability and pharmacodynamics of volixibat in overweight and obese but otherwise healthy adults: implications for treatment of non-alcoholic steatohepatitis
- (2018) Melissa Palmer et al. BMC Pharmacology & Toxicology
- Pharmacological stimulation of p53 with low-dose doxorubicin ameliorates diet-induced nonalcoholic steatosis and steatohepatitis
- (2018) Begoña Porteiro et al. Molecular Metabolism
- MicroRNA-504 functions as a tumor suppressor in hepatocellular carcinoma through inhibiting Frizzled-7-mediated-Wnt/β-catenin signaling
- (2018) Hui Quan et al. BIOMEDICINE & PHARMACOTHERAPY
- Sparstolonin B (SSnB) attenuates liver fibrosisvia a parallel conjugate pathway involving P53-P21 axis, TGF-beta signaling and focal adhesion that is TLR4 dependent
- (2018) Diptadip Dattaroy et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Randomised clinical trial: emricasan versus placebo significantly decreases ALT and caspase 3/7 activation in subjects with non-alcoholic fatty liver disease
- (2018) Mitchell Shiffman et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Secreted modular calcium-binding protein 2 promotes high fat diet (HFD)-induced hepatic steatosis through enhancing lipid deposition, fibrosis and inflammation via targeting TGF-β1
- (2018) Yun Yuting et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Upregulation of miR-181a impairs lipid metabolism by targeting PPARα expression in nonalcoholic fatty liver disease
- (2018) Ruixian Huang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- GS-0976 Reduces Hepatic Steatosis and Fibrosis Markers in Patients With Nonalcoholic Fatty Liver Disease
- (2018) Rohit Loomba et al. GASTROENTEROLOGY
- Pegbelfermin (BMS-986036), a PEGylated fibroblast growth factor 21 analogue, in patients with non-alcoholic steatohepatitis: a randomised, double-blind, placebo-controlled, phase 2a trial
- (2018) Arun Sanyal et al. LANCET
- The ASK1 inhibitor selonsertib in patients with nonalcoholic steatohepatitis: A randomized, phase 2 trial
- (2017) Rohit Loomba et al. HEPATOLOGY
- The origin of fibrogenic myofibroblasts in fibrotic liver
- (2017) Tatiana Kisseleva HEPATOLOGY
- Serum vascular cell adhesion molecule-1 predicts significant liver fibrosis in non-alcoholic fatty liver disease
- (2017) S Lefere et al. INTERNATIONAL JOURNAL OF OBESITY
- New trends on obesity and NAFLD in Asia
- (2017) Jian-Gao Fan et al. JOURNAL OF HEPATOLOGY
- Lobeglitazone, a Novel Thiazolidinedione, Improves Non-Alcoholic Fatty Liver Disease in Type 2 Diabetes: Its Efficacy and Predictive Factors Related to Responsiveness
- (2017) Yong-ho Lee et al. JOURNAL OF KOREAN MEDICAL SCIENCE
- miR-192-5p regulates lipid synthesis in non-alcoholic fatty liver disease through SCD-1
- (2017) Xiao-Lin Liu et al. WORLD JOURNAL OF GASTROENTEROLOGY
- miR-21 ablation and obeticholic acid ameliorate nonalcoholic steatohepatitis in mice
- (2017) Pedro M Rodrigues et al. Cell Death & Disease
- Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening
- (2016) Vlad Ratziu et al. GASTROENTEROLOGY
- Wnt signalling modulates transcribed-ultraconserved regions in hepatobiliary cancers
- (2016) Pietro Carotenuto et al. GUT
- Plasma DNA methylation: a potential biomarker for stratification of liver fibrosis in non-alcoholic fatty liver disease
- (2016) Timothy Hardy et al. GUT
- Stress-activatedmiR-21/miR-21*in hepatocytes promotes lipid and glucose metabolic disorders associated with high-fat diet consumption
- (2016) Nicolas Calo et al. GUT
- The importance of serum biglycan levels as a fibrosis marker in patients with chronic hepatitis B
- (2016) Rafiye Ciftciler et al. JOURNAL OF CLINICAL LABORATORY ANALYSIS
- IGF-I induces senescence of hepatic stellate cells and limits fibrosis in a p53-dependent manner
- (2016) Hitoshi Nishizawa et al. Scientific Reports
- Efficacy of rifaximin on circulating endotoxins and cytokines in patients with nonalcoholic fatty liver disease
- (2015) Venkatanarayana Gangarapu et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Liver microRNA-21 is overexpressed in non-alcoholic steatohepatitis and contributes to the disease in experimental models by inhibiting PPARα expression
- (2015) Xavier Loyer et al. GUT
- Long working hours and risk of coronary heart disease and stroke: a systematic review and meta-analysis of published and unpublished data for 603 838 individuals
- (2015) Mika Kivimäki et al. LANCET
- The effects of DASH diet on weight loss and metabolic status in adults with non-alcoholic fatty liver disease: a randomized clinical trial
- (2015) Mohsen Razavi Zade et al. LIVER INTERNATIONAL
- Effect of miR-34a in regulating steatosis by targeting PPARα expression in nonalcoholic fatty liver disease
- (2015) Jiexia Ding et al. Scientific Reports
- Protective effects of farnesoid X receptor (FXR) on hepatic lipid accumulation are mediated by hepatic FXR and independent of intestinal FGF15 signal
- (2014) Johannes Schmitt et al. LIVER INTERNATIONAL
- Vitamin E and changes in serum alanine aminotransferase levels in patients with non-alcoholic steatohepatitis
- (2013) J. H. Hoofnagle et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Effects of a farnesoid X receptor antagonist on hepatic lipid metabolism in primates
- (2013) Yuichiro Amano et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Efficacy and Safety of the Farnesoid X Receptor Agonist Obeticholic Acid in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease
- (2013) Sunder Mudaliar et al. GASTROENTEROLOGY
- Systematic review of the Hawthorne effect: New concepts are needed to study research participation effects
- (2013) Jim McCambridge et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Post-transcriptional activation of PPAR alpha by KLF6 in hepatic steatosis
- (2013) Lars P. Bechmann et al. JOURNAL OF HEPATOLOGY
- Long Working Hours and Coronary Heart Disease: A Systematic Review and Meta-Analysis
- (2012) M. Virtanen et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Long working hours and metabolic syndrome among Japanese men: a cross-sectional study
- (2012) Tomoko Kobayashi et al. BMC PUBLIC HEALTH
- Hepatic fat loss in advanced nonalcoholic steatohepatitis: Are alterations in serum adiponectin the cause?
- (2012) David van der Poorten et al. HEPATOLOGY
- Rosiglitazone versus rosiglitazone and metformin versus rosiglitazone and losartan in the treatment of nonalcoholic steatohepatitis in humans: A 12-month randomized, prospective, open- label trial
- (2011) Dawn M. Torres et al. HEPATOLOGY
- Validation of the BARD scoring system in Polish patients with nonalcoholic fatty liver disease (NAFLD)
- (2010) Joanna Raszeja-Wyszomirska et al. BMC GASTROENTEROLOGY
- Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease
- (2010) S. McPherson et al. GUT
- Validation of FIB-4 and comparison with other simple noninvasive indices for predicting liver fibrosis and cirrhosis in hepatitis B virus-infected patients
- (2010) Beom Kyung Kim et al. LIVER INTERNATIONAL
- Hepatic steatosis index: A simple screening tool reflecting nonalcoholic fatty liver disease
- (2009) Jeong-Hoon Lee et al. DIGESTIVE AND LIVER DISEASE
- Clinical trial: pilot study of metformin for the treatment of non-alcoholic steatohepatitis
- (2008) R. LOOMBA et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Hepatic Insulin Resistance Is Sufficient to Produce Dyslipidemia and Susceptibility to Atherosclerosis
- (2008) Sudha B. Biddinger et al. Cell Metabolism
- Cellular Sources of Extracellular Matrix in Hepatic Fibrosis
- (2008) Rebecca G. Wells Clinics in Liver Disease
- Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease
- (2008) S A Harrison et al. GUT
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started